Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 4
2007 5
2008 1
2009 1
2010 7
2011 7
2012 8
2013 3
2014 5
2015 1
2017 1
2018 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S, Kurata N, Yamaguchi A, Amagase K, Takeuchi K. Hayashi S, et al. J Pharmacol Exp Ther. 2014 Jun;349(3):470-9. doi: 10.1124/jpet.114.213991. Epub 2014 Apr 8. J Pharmacol Exp Ther. 2014. PMID: 24713141
The effects of lubiprostone on the intestinal lesions and functional alterations were significantly abrogated by the coadministration of AE3-208 [4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)pheny …
The effects of lubiprostone on the intestinal lesions and functional alterations were significantly abrogated by the coadministration of AE3 …
Blockade of prostaglandin E2 receptor 4 ameliorates nephrotoxic serum nephritis.
Aringer I, Artinger K, Kirsch AH, Schabhüttl C, Jandl K, Bärnthaler T, Mooslechner AA, Herzog SA, Uhlig M, Kirsch A, Frank S, Banas M, Pollheimer M, Eller P, Rosenkranz AR, Heinemann A, Eller K. Aringer I, et al. Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1869-F1880. doi: 10.1152/ajprenal.00113.2018. Epub 2018 Oct 17. Am J Physiol Renal Physiol. 2018. PMID: 30332316 Free article.
EP4 receptor as a new target for bronchodilator therapy.
Buckley J, Birrell MA, Maher SA, Nials AT, Clarke DL, Belvisi MG. Buckley J, et al. Thorax. 2011 Dec;66(12):1029-35. doi: 10.1136/thx.2010.158568. Epub 2011 May 23. Thorax. 2011. PMID: 21606476 Free PMC article.
Inhibition of EP4 signaling attenuates aortic aneurysm formation.
Yokoyama U, Ishiwata R, Jin MH, Kato Y, Suzuki O, Jin H, Ichikawa Y, Kumagaya S, Katayama Y, Fujita T, Okumura S, Sato M, Sugimoto Y, Aoki H, Suzuki S, Masuda M, Minamisawa S, Ishikawa Y. Yokoyama U, et al. PLoS One. 2012;7(5):e36724. doi: 10.1371/journal.pone.0036724. Epub 2012 May 3. PLoS One. 2012. PMID: 22570740 Free PMC article.
Prostaglandin receptor EP4 in abdominal aortic aneurysms.
Cao RY, St Amand T, Li X, Yoon SH, Wang CP, Song H, Maruyama T, Brown PM, Zelt DT, Funk CD. Cao RY, et al. Am J Pathol. 2012 Jul;181(1):313-21. doi: 10.1016/j.ajpath.2012.03.016. Epub 2012 May 15. Am J Pathol. 2012. PMID: 22595380 Free article.
42 results